BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study

In patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations are currently determined by tumor sample analysis. Here, we report BRAF mutation status analysis in paired tumor tissue and plasma samples of mCRC patients included in the AGEO RASANC prospective cohort study. Four hundred...

Descripción completa

Detalles Bibliográficos
Autores principales: Mas, Leo, Bachet, Jean-Baptiste, Taly, Valerie, Bouché, Olivier, Taieb, Julien, Cohen, Romain, Meurisse, Aurelia, Normand, Corinne, Gornet, Jean-Marc, Artru, Pascal, Louafi, Samy, Thirot-Bidault, Anne, Baumgaertner, Isabelle, Coriat, Romain, Tougeron, David, Lecomte, Thierry, Mary, Florence, Aparicio, Thomas, Marthey, Lysiane, Blons, Helene, Vernerey, Dewi, Laurent-Puig, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679157/
https://www.ncbi.nlm.nih.gov/pubmed/31319569
http://dx.doi.org/10.3390/cancers11070998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679157/
https://www.ncbi.nlm.nih.gov/pubmed/31319569
http://dx.doi.org/10.3390/cancers11070998

Ejemplares similares